Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Camilla Kilbane, MD

Camilla Kilbane, MD

  • Director, Parkinson’s and Movement Disorder Center, University Hospitals
  • Medical Director, Deep Brain Stimulation Program, UH Cleveland Medical Center
  • Program Director, Movement Disorders, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine
  • Specialty: Neurology-Movement Disorders, Neurology
  • Location:
    University Hospitals
    950 Clague Rd
    Westlake, OH 44145

Biography: Camilla Kilbane, MD


  • Atypical Parkinsonism
  • Chorea
  • Deep Brain Stimulation (DBS)
  • Dystonia
  • Functional Movement Disorders
  • Huntington's Disease
  • Movement Disorders
  • Myoclonus
  • Neurology
  • Parkinson's Disease
  • Tics
  • Tourette's Syndrome
  • Tremors

Certifications & Memberships

  • Neurology - American Board of Psychiatry and Neurology


Fellowship | Movement Disorders
Movement Disorders - University Of California San Francisco (USCF) Medical Center At Parnassus (2010 - 2012)

Residency | Neurology
Neurology - Mount Sinai Hospital (2007 - 2010)

Internship | Internal Medicine
Internal Medicine - Queens Hospital Center (2006 - 2007)

Medical Education
Royal College Of Surgeons In Ireland School Of Medicine (2004)


Camilla Kilbane, MD is a neurologist at University Hospitals Cleveland Medical Center and an Associate Professor of Neurology at Case Western Reserve University School of Medicine. She joined the UH Cleveland Medical Center staff in 2015, after three years on staff as a movement disorder attending at Stanford University Hospital, under the mentorship of Professor Helen Bronte-Stewart. Dr. Kilbane is the Center director and directs the fellowship program in movement disorders in the Parkinson's & Movement Disorders Center. She is the medical director of the Deep Brain Stimulation program.

Dr. Kilbane is board-certified in neurology and psychiatry. Her special interests include movement disorders, dystonia, Parkinson's disease, deep brain stimulation (DBS), functional movement disorders, essential tremor, and neurophysiology. 

Dr. Kilbane completed her medical degree at the Royal College of Surgeons in Dublin, Ireland, after receiving a Norwegian national scholarship to study abroad. She completed an internship at Beaumont Hospital in Dublin, Ireland, before moving to the U.S. She did a U.S. internship at Queens Hospital Center in Queens, N.Y. Dr. Kilbane completed her neurology residency at Mount Sinai Medical Center in New York City, serving as chief resident, and completed two years of fellowship training in movement disorders and intra-operative physiology at the University of California San Francisco, under the mentorship of Professor Ostrem and Professor Starr.

Dr. Kilbane participates in clinical trials of investigational drugs and devices to treat Parkinson's disease and other movement disorders. She is the author or co-author of over 25 publications in peer-reviewed medical journals. She has presented abstracts at many international and national peer-reviewed medical conferences. Dr. Kilbane is a member of the American Academy of Neurology, the Movement Disorder Society, the Parkinson's disease Study Group, the Functional Neurological Disorder Society and the Dystonia Coalition. She serves on the Membership and CME committee of the Movement Disorder Society.  She is a fellow of the American Academy of Neurology. She was selected for the Women Leading in Neurology leadership program in 2022.

Research & Publications

Research Interests

Movement Disorders, Deep Brain Stimulation, Botulinum Toxin Injection, Parkinson Disease, Functional Movement Disorders, Tremor, Huntington's Disease

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Camilla Kilbane did not disclose any Outside Relationships with Industry.